These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17482105)

  • 1. Bivalirudin in peripheral interventions.
    Maclean AA; Peña CS; Katzen BT
    Tech Vasc Interv Radiol; 2006 Jun; 9(2):80-3. PubMed ID: 17482105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bivalirudin, a bivalent, thrombin specific anticoagulant as an alternative to heparin in interventional procedures as an alternative to heparin in interventional procedures.
    Chew DP
    Hamostaseologie; 2002 Aug; 22(3):60-6. PubMed ID: 12215763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bivalirudin (Angiomax) for angioplasty.
    Med Lett Drugs Ther; 2001 Apr; 43(1103):37-8. PubMed ID: 11331441
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacology and clinical use of bivalirudin.
    Sciulli TM; Mauro VF
    Ann Pharmacother; 2002 Jun; 36(6):1028-41. PubMed ID: 12022907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful use of bivalirudin for cardiac transplantation in a child with heparin-induced thrombocytopenia.
    Almond CS; Harrington J; Thiagarajan R; Duncan CN; LaPierre R; Halwick D; Blume ED; Del Nido PJ; Neufeld EJ; McGowan FX
    J Heart Lung Transplant; 2006 Nov; 25(11):1376-9. PubMed ID: 17097505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bivalirudin.
    Warkentin TE; Greinacher A; Koster A
    Thromb Haemost; 2008 May; 99(5):830-9. PubMed ID: 18449412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of heparin-induced thrombocytopenia: is there a role for bivalirudin?
    Seybert AL; Coons JC; Zerumsky K
    Pharmacotherapy; 2006 Feb; 26(2):229-41. PubMed ID: 16466327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bivalirudin: a review of the pharmacology and clinical application.
    Van De Car DA; Rao SV; Ohman EM
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1673-81. PubMed ID: 21108549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bivalirudin as an anticoagulant during percutaneous coronary interventions in acute coronary syndromes: strengths and doubts].
    Savonitto S; Morici N
    Rev Esp Cardiol; 2011 May; 64(5):361-4. PubMed ID: 21482005
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulation in children: Making the most of little patients and little evidence.
    Young G; Male C; van Ommen CH
    Blood Cells Mol Dis; 2017 Sep; 67():48-53. PubMed ID: 28552476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bivalirudin during primary PCI in acute myocardial infarction.
    Stone GW; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Kornowski R; Hartmann F; Gersh BJ; Pocock SJ; Dangas G; Wong SC; Kirtane AJ; Parise H; Mehran R;
    N Engl J Med; 2008 May; 358(21):2218-30. PubMed ID: 18499566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiopulmonary bypass with bivalirudin in type II heparin-induced thrombocytopenia.
    Clayton SB; Acsell JR; Crumbley AJ; Uber WE
    Ann Thorac Surg; 2004 Dec; 78(6):2167-9. PubMed ID: 15561064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric catheterization laboratory anticoagulation with bivalirudin.
    Forbes TJ; Hijazi ZM; Young G; Ringewald JM; Aquino PM; Vincent RN; Qureshi AM; Rome JJ; Rhodes JF; Jones TK; Moskowitz WB; Holzer RJ; Zamora R
    Catheter Cardiovasc Interv; 2011 Apr; 77(5):671-9. PubMed ID: 21433272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of bivalirudin versus heparins in reduction of cardiac outcomes in acute coronary syndrome and percutaneous coronary interventions.
    Singh S; Molnar J; Arora R
    J Cardiovasc Pharmacol Ther; 2007 Dec; 12(4):283-91. PubMed ID: 18172222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct thrombin inhibition with bivalirudin as an antithrombotic strategy in general and interventional cardiology.
    Ahrens I; Smith BK; Bode C; Peter K
    Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):609-20. PubMed ID: 17696810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bivalirudin as an anticoagulation agent: safety and efficacy in peripheral interventions.
    Katzen BT; Ardid MI; MacLean AA; Kovacs MF; Zemel G; Benenati JF; Powell A; Samuels S
    J Vasc Interv Radiol; 2005 Sep; 16(9):1183-7; quiz 1187. PubMed ID: 16151058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bivalirudin for patients with acute coronary syndromes.
    Stone GW; McLaurin BT; Cox DA; Bertrand ME; Lincoff AM; Moses JW; White HD; Pocock SJ; Ware JH; Feit F; Colombo A; Aylward PE; Cequier AR; Darius H; Desmet W; Ebrahimi R; Hamon M; Rasmussen LH; Rupprecht HJ; Hoekstra J; Mehran R; Ohman EM;
    N Engl J Med; 2006 Nov; 355(21):2203-16. PubMed ID: 17124018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current incidence and clinical outcomes of bivalirudin administration among patients undergoing primary coronary intervention for stent thrombosis elevation acute myocardial infarction.
    Dauerman HL; Frederick PD; Miller D; French WJ;
    Coron Artery Dis; 2007 Mar; 18(2):141-8. PubMed ID: 17301606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and/or renal dysfunction.
    Kiser TH; Fish DN
    Pharmacotherapy; 2006 Apr; 26(4):452-60. PubMed ID: 16553502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
    Dang CH; Durkalski VL; Nappi JM
    Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.